Matthias P. Wymann

Matthias P. Wymann

Universität Basel

H-index: 68

Europe-Switzerland

About Matthias P. Wymann

Matthias P. Wymann, With an exceptional h-index of 68 and a recent h-index of 33 (since 2020), a distinguished researcher at Universität Basel, specializes in the field of inflammation, cancer, cellular signaling, phosphoinositides, PI3K.

His recent articles reflect a diverse array of research interests and contributions to the field:

An evolutionary-conserved VPS34-PIKfyve-TRPML1-Myosin II axis regulates the speed of amoeboid cell migration

A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα

Novel long-acting covalent PI3Kα inhibitors boost potential action in cancer

Correction: A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα

Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor

Optogenetic control of PI3K gamma reveals its role in smooth muscle cell contractility.

Stereospecific synthesis of substituted sulfamidates as privileged morpholine building blocks

The role of PI3Kγ in the immune system: new insights and translational implications

Matthias P. Wymann Information

University

Position

Department of Biomedicine Switzerland

Citations(all)

22942

Citations(since 2020)

4228

Cited By

20194

hIndex(all)

68

hIndex(since 2020)

33

i10Index(all)

118

i10Index(since 2020)

85

Email

University Profile Page

Universität Basel

Google Scholar

View Google Scholar Profile

Matthias P. Wymann Skills & Research Interests

inflammation

cancer

cellular signaling

phosphoinositides

PI3K

Top articles of Matthias P. Wymann

Title

Journal

Author(s)

Publication Date

An evolutionary-conserved VPS34-PIKfyve-TRPML1-Myosin II axis regulates the speed of amoeboid cell migration

bioRxiv

Philippe Dehio

Céline Michard

Juan Carlos Yam-Puc

Adrià-Arnau Martí i Líndez

Lucien Fabre

...

2024

A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα

Chemical Science

Werner Theodor Jauslin

Matthias Schild

Thorsten Schaefer

Chiara Borsari

Clara Orbegozo

...

2024

Novel long-acting covalent PI3Kα inhibitors boost potential action in cancer

Cancer Research

Theodora A Constantin

Lukas Bissegger

Erhan Keleş

Luka Raguž

Clara Orbegozo

...

2024/3/22

Correction: A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα

Chemical Science

Werner Theodor Jauslin

Matthias Schild

Thorsten Schaefer

Chiara Borsari

Clara Orbegozo

...

2024

Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor

European Journal of Medicinal Chemistry

Martina De Pascale

Lukas Bissegger

Chiara Tarantelli

Florent Beaufils

Alessandro Prescimone

...

2023/2/15

Optogenetic control of PI3K gamma reveals its role in smooth muscle cell contractility.

Artery Research

Damien Rame

Marie-Kergulen Sarthou

Amandine Wahart

Nicole Malet

Stéphanie Gayral

...

2023/2/2

Stereospecific synthesis of substituted sulfamidates as privileged morpholine building blocks

Synthesis

Uros Stojiljkovic

Claudio Meyer

Pierre Boulay

Paul Hebeisen

Denise Rageot

...

2023/2

The role of PI3Kγ in the immune system: new insights and translational implications

Stephen M Lanahan

Matthias P Wymann

Carrie L Lucas

2022/11

Synthesis of Versatile Enantiopure Morpholine Fragments from Chiral-Pool Starting Materials

U STOJILJKOVIC

C MEYER

P BOULAY

P HEBEISEN

D RAGEOT

...

2022

Composto, composição farmacêutica e método para modular a atividade de pdk e pkb

2022/10/4

Two-drug trick to target the brain blocks toxicity in the body

Matthias P Wymann

Chiara Borsari

2022/9/22

Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines

2022/5/19

Covalent proximity scanning of a distal cysteine to target PI3Kα

Journal of the American Chemical Society

Chiara Borsari

Erhan Keles

Jacob A McPhail

Alexander Schaefer

Rohitha Sriramaratnam

...

2022/3/30

Development of optimized chemical probes targeting PI3Ka to deconvolute the role of class I PI3Ks isoforms in insulin signaling

Cancer Research

Martina De Pascale

Chiara Borsari

Erhan Keles

Jacob McPhail

Alexander Schäfer

...

2021/7/1

Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner

2021/8/30

Volume scanning, a rational approach to covalent PI3Kα inhibitors

Cancer Research

Chiara Borsari

Erhan Keles

Jacob McPhail

Alexander Schäfer

Rohitha Sriramaratnam

...

2021/7/1

Suppression of caspase 8 activity by a coronin 1–PI3Kδ pathway promotes T cell survival independently of TCR and IL-7 signaling

Science signaling

Mayumi Mori

Julie Ruer-Laventie

Wandrille Duchemin

Philippe Demougin

Tohnyui Ndinyanka Fabrice

...

2021/12/21

Disease related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors

Elife

Manoj K Rathinaswamy

Zied Gaieb

Kaelin D Fleming

Chiara Borsari

Noah J Harris

...

2021/3/4

Targeting Phosphoinositide 3-Kinase–Five Decades of Chemical Space Exploration

Chimia

Chiara Borsari

Matthias P Wymann

2021/12/9

A novel, highly potent PI3Kα covalent inhibitor deconvolutes class I PI3K isoforms in cancer cells

Cancer Research

Erhan Keles

Chiara Borsari

Rohitha Sriramaratnam

Thorsten Schäfer

Matthias P Wymann

2021/7/1

See List of Professors in Matthias P. Wymann University(Universität Basel)

Co-Authors

H-index: 110
Silvano Sozzani

Silvano Sozzani

Brescia University

H-index: 90
Emilio Hirsch

Emilio Hirsch

Università degli Studi di Torino

H-index: 90
Bart Vanhaesebroeck

Bart Vanhaesebroeck

University College London

H-index: 68
Abdul Dulloo

Abdul Dulloo

Université de Fribourg

H-index: 48
John E Burke

John E Burke

University of Victoria

academic-engine